We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Hong Kong SAR, China - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Hong Kong SAR, China - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Hong Kong SAR, China: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Hong Kong SAR, China

In 2021, the Hong Kong market for medicaments of alkaloids or derivatives thereof decreased by -X% to $X for the first time since 2015, thus ending a five-year rising trend. Overall, consumption posted a buoyant increase. As a result, consumption attained the peak level of $X. From 2015 to 2021, the growth of the market remained at a lower figure.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in Hong Kong SAR, China

In value terms, production of medicaments of alkaloids or derivatives thereof fell slightly to $X in 2021 estimated in export price. Overall, production continues to indicate a mild decline. The most prominent rate of growth was recorded in 2014 when the production volume increased by X%. As a result, production reached the peak level of $X. From 2015 to 2021, production of growth failed to regain momentum.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from Hong Kong SAR, China

Exports of medicaments of alkaloids or derivatives thereof from Hong Kong SAR reduced to X tons in 2021, approximately reflecting the year before. In general, exports recorded a deep slump. The growth pace was the most rapid in 2014 with an increase of X% against the previous year. The exports peaked at X tons in 2012; however, from 2013 to 2021, the exports failed to regain momentum.

In value terms, exports of medicaments of alkaloids or derivatives thereof amounted to $X in 2021. Over the period under review, exports, however, enjoyed notable growth. The growth pace was the most rapid in 2014 with an increase of X% against the previous year. As a result, the exports reached the peak of $X. From 2015 to 2021, the growth of the exports of remained at a lower figure.

Exports by Country

China (X tons) was the main destination for exports of medicaments of alkaloids or derivatives thereof from Hong Kong SAR, accounting for a approx. X% share of total exports.

From 2012 to 2021, the average annual growth rate of volume to China stood at -X%.

In value terms, China ($X) also remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from Hong Kong SAR.

From 2012 to 2021, the average annual growth rate of value to China amounted to +X%.

Export Prices by Country

In 2021, the average export price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, growing by X% against the previous year. In general, the export price enjoyed buoyant growth. The most prominent rate of growth was recorded in 2013 when the average export price increased by X%. The export price peaked in 2021 and is expected to retain growth in years to come.

As there is only one major export destination, the average price level is determined by prices for China.

From 2012 to 2021, the rate of growth in terms of prices for China amounted to +X% per year.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into Hong Kong SAR, China

In 2021, overseas purchases of medicaments of alkaloids or derivatives thereof decreased by -X% to X tons, falling for the third year in a row after two years of growth. Over the period under review, imports recorded a deep setback. The most prominent rate of growth was recorded in 2015 when imports increased by X%. Imports peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, imports of medicaments of alkaloids or derivatives thereof dropped modestly to $X in 2021. Overall, imports continue to indicate a deep reduction. The pace of growth was the most pronounced in 2016 when imports increased by X%. Imports peaked at $X in 2012; however, from 2013 to 2021, imports failed to regain momentum.

Imports by Country

China (X tons), the UK (X tons) and Singapore (X tons) were the main suppliers of imports of medicaments of alkaloids or derivatives thereof to Hong Kong SAR, with a combined X% share of total imports.

From 2012 to 2021, the biggest increases were in Singapore (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Italy ($X), Malaysia ($X) and Singapore ($X) appeared to be the largest medicaments of alkaloids or derivatives thereof suppliers to Hong Kong SAR, with a combined X% share of total imports.

Singapore, with a CAGR of +X%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average import price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, rising by X% against the previous year. Over the period under review, the import price, however, continues to indicate a perceptible reduction. The pace of growth appeared the most rapid in 2016 an increase of X%. Over the period under review, average import prices attained the maximum at $X per ton in 2014; however, from 2015 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Italy ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Malaysia (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

China constituted the country with the largest volume of consumption of medicaments of alkaloids or derivatives thereof, accounting for 22% of total volume. Moreover, consumption of medicaments of alkaloids or derivatives thereof in China exceeded the figures recorded by the second-largest consumer, India, twofold. The third position in this ranking was occupied by the United States, with a 6.6% share.
The country with the largest volume of production of medicaments of alkaloids or derivatives thereof was China, comprising approx. 24% of total volume. Moreover, production of medicaments of alkaloids or derivatives thereof in China exceeded the figures recorded by the second-largest producer, India, twofold. The United States ranked third in terms of total production with a 7.4% share.
In value terms, the largest medicaments of alkaloids or derivatives thereof suppliers to Hong Kong SAR were Italy, Malaysia and Germany, with a combined 63% share of total imports. These countries were followed by the UK, Singapore, China and South Korea, which together accounted for a further 19%.
In value terms, China remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from Hong Kong SAR.
The average export price for medicaments of alkaloids or derivatives thereof stood at $15,735 per ton in 2020, rising by 7.1% against the previous year.
In 2020, the average import price for medicaments of alkaloids or derivatives thereof amounted to $10,587 per ton, with a decrease of -10.7% against the previous year.

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Hong Kong SAR, China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201310 - Medicaments of alkaloids or derivatives thereof, n.p.r.s.
  • Prodcom 21201340 - Medicaments of alkaloids or derivatives thereof, p.r.s.

Country coverage:

  • Hong Kong SAR

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Hong Kong SAR, China
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023

  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

World - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 296

This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.

EU - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 115

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the EU.

Asia - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 131

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Asia.

U.S. - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 120

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the U.S..

China - Medicaments of Alkaloids or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 131

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in China.

Free Data: Medicaments of Alkaloids or Derivatives Thereof - Hong Kong SAR
Table
Medicaments of Alkaloids or Derivatives Thereof - Hong Kong SAR - Table
Dashboard
Medicaments of Alkaloids or Derivatives Thereof - Hong Kong SAR - Dashboard
Report
Medicaments of Alkaloids or Derivatives Thereof - Hong Kong SAR - Report